分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Sequential resolution of (S) and (R)-6-fluoro-chroman-2-carboxylic acid by two esterases in turn

Min Jiang, Yong-Jun Liu, Guo-Song Liu, Wei Zhou, Ya-Ling Shen, Bei Gao, Feng-Qing Wang, Dong-Zhi Wei

Journal:GREEN CHEMISTRY

IF:11.03

DOI:10.1039/D1GC04512A

PMID:

Published:2022-03-14

research field:化学工程生物技术生物化学

Abstract

Optically pure 6-fluoro-chroman-2-carboxylic acids (FCCAs), with (S) and (R)-configurations, are pivotal chiral building blocks in the pharmaceutical industry. To date, the production of (S) and (R)-FCCAs mainly depends on chemical resolution, which is a complex, low yield, and highly polluting process. Here, we present a practical enzymatic resolution method of FCCAs based on two esterases, EstS and EstR, isolated from Geobacillus thermocatenulatus. Using the racemic methyl 6-fluoro-chroman-2-carboxylate (MFCC) as the substrate in an aqueous–toluene biphasic system, (S) and (R)-FCCAs were produced by EstS and EstR catalysis with an enantiomeric excess (ee) value >99% and 95–96%, respectively, and the highly enantioselective mechanisms were revealed by molecular simulations. To simplify the resolution process and enhance the productivity, we further designed an innovative methodology for the “sequential biphasic batch resolution” of MFCC with immobilized cells. In each batch, only the aqueous phase needs to be replaced to sequentially change the immobilized cells of EstS or EstR and recover optically pure FCCAs in turn, while the organic phase was retained and MFCC was continually supplemented after every two batches. In this study, ten batches of sequential resolution were performed, and 229.3 mM (S)-FCCAs with 96.9% ee, and 224.1 mM (R)-FCCAs with 99.1% ee were obtained in 40 h, affording a 93.5% total mole yield. This is the first reported enzymatic resolution technique of FCCAs, and represents significant advantages over those chemical resolution methods.

本文使用的Yeasen产品

购物车
客服
转染试用